Stanford University
Showing 101-120 of 160 Results
-
Joel Neal, MD, PhD
Professor of Medicine (Oncology)
Current Research and Scholarly InterestsI am a thoracic oncologist who cares for patients with non-small cell lung cancer, malignant mesothelioma, and other thoracic malignancies. I design and conduct clinical trials of novel therapies in collaboration with other researchers and pharmaceutical companies. These generally focus on two areas, 1) targeted therapies against particular mutations in cancers (for example EGFR, ALK, ROS1, HER2, KRAS, MET, and others) and 2) the emerging field of immunotherapy in cancer, using anti PD-1/PD-L1 therapies in combination with other agents, and also developing cellular therapies. I also collaborate with other researchers on campus to apply emerging technologies to cancer therapy, for example, circulating tumor DNA detection. Additionally, in my role as the Cancer Center IT Medical Director, I coordinate projects relating to our use of the electronic health record to improve provider efficiency and facilitate patient care.
-
Dale Gene O'Brien
Adjunct Clinical Assistant Professor, Medicine - Oncology
BioDale O’Brien, MD, MPH is adjunct faculty at the Stanford University School of Medicine in the Oncology Division. He founded several medical clinics for vulnerable populations in under-resourced areas of northern California where he has been a practicing physician for more than four decades.
A graduate of the University of Missouri School of Medicine, he took postgraduate training at the Oregon Health & Science University, and the University of California (San Francisco) / University of California School of Public Health. He is board certified by the American Board of Family Medicine and by the American Board of Preventive Medicine.
Dr. O'Brien treated hippies at the White Bird Clinic in Eugene, Oregon in the mid-70s; served as the acting Health Officer of the Shasta County Health Department in California; and spent two years in the early 80s as an affiliate of the European Branch Headquarters of the World Health Organization in Denmark.
As the Executive Director of the nonprofit Cancer Patients Alliance (CPA) since 2001, Dr. O’Brien and his team have advocated for and supported low-income Latino community members, immigrants and farm workers with cancer in the Salinas Valley agricultural region of Monterey County, California.
Dr. O’Brien was Co-Principal Investigator of the Stanford Cancer Institute's Developmental Research Award in Translational Science, "Building an Academic-Community Partnership to Understand and Address Barriers to Cancer Care in the Salinas Valley Region of Monterey County," 2010 – 2015.
CPA has trained a number of Stanford University medical and post-doctoral students on behalf of the Valley Fellowship Program beginning in 2010 until the present.
Dr. O'Brien was a member of the Stanford / Medable team that developed the cancer aftercare app called TOGETHERCare - per NIH / NCI (SBIR 363) Phase 1 and 2 grants from 9/18/2017 until 9/30/2022.
Dr. O’Brien was on the Stanford-based research team in 2018 that piloted and studied the efficacy of the “Healthkey” behavioral health app for SAMHSA, CDC and the Council of State and Territorial Epidemiologists.
Beginning 2019, he was Co-Principal Investigator with the Stanford University group that has helped reduce cancer disparities by increasing access to the emerging DNA technologies - and facilitating cultural translation in Monterey County - pursuant to 4-year support from the California Initiative to Advance Precision Medicine.
In 2021, CPA received a 5-year grant award from the Robert Wood Johnson Foundation to further their advocacy work with the Latino community and farm workers with cancer in the Salinas Valley.
In June 2021, CPA was selected by the California GOTV medical academic consortium including the Stanford University School of Medicine as led by UCLA - to conduct the "Get Out the Vaccine to Stop Covid-19" initiative for low-income populations in Monterey County, California.
Dr. O'Brien was awarded a grant from SAMHSA through the California Department of Health Care Services (administered by Sierra Health Foundation) as the Lead for the 2024-2025 collaborative consisting of CPA, Monterey County Behavioral Health, Mujeres en Acción, and NAMI Monterey County for the "Behavioral Health Recovery, Access and Equity for Latinos" (BHRAEL) initiative.
Since 2016 Dr. O'Brien has been on the Institutional Review Board of Clinica de Salud del Valle de Salinas. He is currently a member of the Stanford Cancer Institute Community Advisory Board. Dr. O’Brien is a past editor of the Berkeley Wellness Letter, Medicine on the Net and Cancer Informatics. -
Judy Yang Pagtama, MSN, RN, FNP-C
Affiliate, Medicine - Med/Oncology
BioJudy Pagtama, MSN, RN, FNP-C is a nurse practitioner in thoracic oncology at the Stanford Cancer Center. She graduated with her Family Nurse Practitioner (FNP) degree from the University of California Los Angeles School of Nursing in 2009. Her area of clinical practice is thoracic oncology, specializing in lung cancer, thymic malignancies, and mesothelioma.
-
Minggui Pan, MD, PhD
Clinical Professor, Medicine - Oncology
BioDr. Pan is a board-certified, fellowship-trained medical oncologist with the Stanford Medicine Cancer Center and a clinical professor in the Department of Medicine, Division of Oncology.
He diagnoses and treats various oncological conditions and specializes in the treatment of bone and soft tissue sarcoma. He creates personalized and comprehensive care plans for each patient he serves.
Dr. Pan’s research focuses include understanding how genomic alterations impact the biological behavior and prognosis of sarcomas. In his work, he identifies new targets for developing innovative therapeutics for sarcoma treatment.
Dr. Pan has more than eighty publications and presented many abstracts in several cancer and immunology conferences. His papers have been published in the Journal of Clinical Oncology, JCO Precision Oncology, Clinical Cancer Research, Nature Review Clinical Oncology, Nature Nanotechnology, Frontier Endocrinology, JCO Oncology Practice, Journal of Hematology and Oncology, British Journal of Cancer Reports, and other peer-reviewed journals. He has also presented to his peers at international, national, and regional meetings, including the annual meetings of American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR), European Society for Medical Oncology (ESMO), Chinese Society Of Clinical Oncology (CSCO), Connective Tissue Oncology Society (CTOS) and others.
Dr. Pan is a member of American Society of Clinical Oncology, American Association for Cancer Research, American Association of Immunologists, American Association for Advancement of Science, Society for Immunotherapy of Cancer, and Connective Tissue Oncology Society. Dr. Pan is also an adjunct investigator with Kaiser Permanente Division of Research. -
Divya Parikh, MD
Clinical Assistant Professor, Medicine - Oncology
BioDr. Divya Parikh is board-certified in both medical oncology and internal medicine. She obtained her medical degree from Boston University School of Medicine and completed both her residency and fellowship through Stanford University. During her fellowship, she simultaneously earned a Master of Science in health policy from Stanford University.
Dr. Parikh specializes in the care of patients with genitourinary cancers. In addition to her clinical responsibilities, she currently is a clinical assistant professor of medical oncology at Stanford School of Medicine. She mentors medical residents and fellows by sharing her insights, knowledge, and expertise.
Dr. Parikh has a strong research background. She has published in multiple academic journals and presented her findings through poster and oral presentations at various medical conferences. -
Neha Patel, MD
Clinical Assistant Professor, Medicine - Oncology
BioDr. Neha Patel is a triple board-certified, fellowship-trained medical oncologist with Stanford Health Care. She is also a clinical assistant professor in the Department of Medicine, Division of Oncology at Stanford University School of Medicine.
Dr. Patel provides expert, personalized care for patients with both common and rare cancers and specializes in treating patients with genitourinary cancer. She is deeply committed to delivering comprehensive, patient-centered oncology services, with an emphasis on helping individuals and their families understand their diagnosis and navigate treatment options with confidence and clarity.
Her research focuses on designing and implementing system-level interventions to advance equitable, high-value cancer care. Dr. Patel is particularly passionate about integrating oncology and palliative (symptom-relieving) care—creating collaborative models that improve patient outcomes, elevate the quality of life, and enhance the overall care experience.
Known for her compassionate and relational approach, Dr. Patel builds strong, trusting partnerships with the patients and families she serves. She prioritizes care that aligns with each individual’s values, preferences, and goals, with the aim of achieving the best possible quality of life and longevity. -
Mark Pegram
Susy Yuan-Huey Hung Professor
Current Research and Scholarly InterestsMolecular mechanisms of targeted therapy resistance in breast and other cancers
-
Harlan Pinto
Associate Professor of Medicine (Oncology), Emeritus
Current Research and Scholarly InterestsClinical Interests: general oncology, head and neck cancer Research Interests: chemoprevention trials and combined modality approaches to head and neck cancer
-
Klaus Porzig
Emeritus Adjunct Clinical Professor, Medicine - Oncology
BioKlaus Porzig is an Emeritus Adjunct Clinical Professor at Stanford. He was active in Stanford’s clinical oncology program from 1979 until 2008. He was an Attending Physician on the Oncology inpatient service (MED III initially and then MED X) annually from 1979 until retirement in 2008. He was active in the breast cancer program during those decades. Dr. Porzig was a founding partner in South Bay Oncology in 1979 which became part of the Stanford Cancer Center in the Southbay after his retirement. From 2013 to 2021, he was a member of the Stanford Medicine Alumni Association Board of Governors and served as chair of the Awards Committee during that time. Klaus has been a docent at Stanford's Jasper Ridge Biological Preserve since 2018.
PROFESSIONAL EDUCATION
B.A., Stanford University, Biology “With Great Distinction” and “Departmental Honors” (1969)
M.D., Stanford University School of Medicine (1973)
POSTGRADUATE TRAINING
Internship: Internal Medicine, University of California, San Francisco (1973-74)
Residency: Internal Medicine, Stanford (1974-75)
Research Fellowship: Laboratory of Cellular and Molecular Biology, National Cancer Institute, NIH (1976-78)
Clinical Fellowship: Medical Oncology, Stanford University (1975-76, 1978-79)
ACADEMIC HONORS AND AWARDS
Phi Beta Kappa (1968)
Alpha Omega Alpha (1972)
Winslow J. Cutting Book Award for research in Pharmacology, Stanford (1973)
Russel V. Lee Clinical Teaching Award for Excellence in Clinical Teaching, Medicine, Stanford (1994,1997,1999, and 2000)
Thomas E. Davis Award for Clinical Teaching, Oncology, Stanford (1995)
Honorary Lifetime Medical Staff, Stanford University Hospital (2013) -
Kavitha Ramchandran
Clinical Professor, Medicine - Oncology
Current Research and Scholarly InterestsMy research focuses on innovative models of care delivey to understand how to integrate primary and specialist palliative care. We also do work in palliative care education and how to scale our education to be impactful and sustainable. We are evaluating online models.
In cancer care I do research on novel therapeutics in thoracic malignancies including immunotherapy, new targeted agents, and new sequencing of approved drugs. -
Julia D. Ransohoff
Instructor, Medicine - Oncology
BioDr. Ransohoff received her B.A. from Harvard College in Human Developmental and Regenerative Biology and completed her medical training at Stanford University, where she received her M.D., completed residency in internal medicine, and fellowship training in hematology and oncology as part of the American Board of Internal Medicine Physician Scientist Training Program.
Dr. Ransohoff is a physician-scientist dedicated to improving breast cancer treatments and outcomes through developing genomic methods to profile how tumors respond to treatment. Her research focuses on molecular approaches to understand the variable clinical responses of breast cancers to treatment at the genomic level by profiling molecular residual disease. Her current work involves exploring mechanisms of chemoresistance and immune evasion and identifying novel therapeutic targets. In related work, she also studies epidemiological risk factors for breast cancer mortality with a focus on the gut microbiome, oncofertility, and racial and ethnic differences in treatment response. Dr. Ransohoff's research has been supported by the ASCO Conquer Cancer Foundation, the Terri Brodeur Breast Cancer Foundation, the Stanford Cancer Institute, ECOG-ACRIN, and the Chan Zuckerberg Initiative.
As an Instructor in the Division of Medical Oncology, Dr. Ransohoff is also a clinically active oncologist, treating patients with breast cancer.
